Drugs for the prevention and treatment of Alzheimer's disease
- 1 October 1997
- journal article
- review article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 167 (8) , 447-452
- https://doi.org/10.5694/j.1326-5377.1997.tb126661.x
Abstract
Alzheimer's disease affects up to 100000 people in Australia, but pharmacological treatment has only been available in recent years. Currently available drugs provide modest relief of symptoms for varying periods of time but have no proven preventive action against the disease.Keywords
This publication has 34 references indexed in Scilit:
- Aspirin, anti-inflammatory drugs and risk of dementiaInternational Journal of Geriatric Psychiatry, 1997
- Risk of Alzheimer's disease and duration of NSAID useNeurology, 1997
- 318 Anti-inflammatory drug use and risk of incident Alzheimer's disease in a defined community populationNeurobiology of Aging, 1996
- Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: A current appraisalNeurobiology of Aging, 1996
- Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's diseaseNeurology, 1996
- Is There a Role for Estrogen Replacement Therapy in the Prevention and Treatment of Dementia?Journal of the American Geriatrics Society, 1996
- Estrogen Replacement Therapy in Older WomenArchives of Neurology, 1994
- Environmental risk factors for Alzheimer's disease: their relationship to age of onset and to familial or sporadic typesPsychological Medicine, 1992
- A case‐control study of Alzheimer's disease in AustraliaNeurology, 1990
- Observations in a preliminary open trial of estradiol therapy for senile dementia-alzheimer's typePsychoneuroendocrinology, 1986